ClotCare: Blood Clots, Stroke, Heart Attack
Tuesday, May 28, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

New Supplement Devoted to Factor Xa Inhibitors (fondaparinux)

Henry I. Bussey, Pharm.D.
August 2004

This supplement to the journal, Pharmacotherapy (Vol 24, Issue 7, Part 2, July, 2004), addresses current issues regarding the limitations of traditional anticoagulants and the evolving role of factor Xa inhibitors for short-term and long-term prophylaxis in orthopedic surgery, for treatment of venous thromboembolism, and for management of heparin-induced thrombocytopenia. The differential effects of anticoagulants on wound healing, and the pharmacoeconomics of thrombosis management also are discussed.

With the permission of Pharmacotherapy, we have made each article from the supplement available in pdf format. Click on an article's title to view the pdf.

Introduction-Current Concepts in Thrombosis Management: Focus on Factor Xa Inhibition
Authors: Edith A. Nutescu, Pharm.D.

Limitations of Traditional Anticoagulants
Authors: David Hawkins, Pharm.D.

Emerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data
Authors: Bob L. Lobo, Pharm.D.

Evidence for Extended Prophylaxis in the Setting of Orthopedic Surgery
Authors: Paul P. Dobesh, Pharm.D.

Evolving Concepts in the Treatment of Venous Thromboembolism: The Role of Factor Xa Inhibitors
Authors: Edith A. Nutescu, Pharm.D. and Cathy M. Helgason, M.D.

Special Considerations with Fondaparinux Therapy: Heparin-Induced Thrombocytopenia and Wound Healing
Authors: William E. Dager, Pharm.D., FCSHP, Judith Andersen, M.D. and Edith Nutescu, Pharm.D.

Pharmacoeconomics of Thrombosis Management
Authors: David Hawkins, Pharm.D.

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to
Tuesday, May 28, 2024